Smoking does influence disease behaviour and impacts the need for therapy in Crohn′s disease in the biologic era

Abstract

These results suggest that, despite the widespread use of immunosuppressants and anti-TNF drugs, smokers with Crohn's disease still have a more severe disease course, with increased therapeutic requirements when compared with nonsmokers.